Intelligence Β· Drug directory

FDA-Approved Drugs Directory

US FDA-approved and listed pharmaceutical products with Drugs@FDA-derived regulatory status, brand names, and pipeline cross-links.

Quick answer

FDA-approved drugs: NovaPharmaNews tracks 2,719 pharmaceutical drugs in this segment. US FDA-approved and listed pharmaceutical products with Drugs@FDA-derived regulatory status, brand names, and pipeline cross-links.

2,719 drugs Β· FDA approved Β· by data quality Β· Page 61 of 114

  1. elbasvir

    ZEPATIER

    ORAL FDA: approved Β· EMA: approved Β· PMDA: approved

    J05AP54
  2. elinzanetant

    LYNKUET

    ORAL FDA: approved Β· EMA: approved

  3. elotuzumab

    EMPLICITI Bristol-Myers Squibb Australia Pty Ltd

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    L01FX08
  4. elranatamab

    ELREXFIO Pfizer Australia Pty Ltd

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved

  5. eluxadoline

    TRUBERZI

    ORAL FDA: approved Β· EMA: withdrawn

    A07
  6. elvitegravir

    GENVOYA

    ORAL FDA: approved Β· EMA: approved

    J05AR
  7. emapalumab-lzsg

    GAMIFANT

    INJECTION FDA: approved

  8. emedastine difumarate

    EMADINE

    OPHTHALMIC FDA: approved

  9. emicizumab

    HEMLIBRA

    INJECTION FDA: approved Β· EMA: approved Β· PMDA: approved

    B02BX06
  10. empagliflozin

    JARDIANCE Boehringer Ingelheim Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    A10BD19
  11. emtricitabine, tenofovir alafenamide

    EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

    ORAL FDA: approved

  12. enalaprilat

    ENALAPRILAT

    INJECTION FDA: approved

  13. enasidenib mesylate

    IDHIFA

    ORAL FDA: approved

  14. encorafenib

    BRAFTOVI Pierre Fabre Australia Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    L01EC03
  15. enflurane

    ENFLURANE

    INHALATION FDA: approved

  16. enfortumab vedotin-ejfv

    PADCEV

    INJECTION FDA: approved

  17. enfuvirtide

    FUZEON

    SUBCUTANEOUS FDA: approved Β· EMA: approved

    J05AX07
  18. enoxacin

    PENETREX

    ORAL FDA: approved

  19. ensartinib hydrochloride

    ENSACOVE

    ORAL FDA: approved

  20. ensifentrine

    OHTUVAYRE

    INHALATION FDA: approved Β· EMA: application withdrawn

    R03BX
  21. entrectinib

    ROZLYTREK Hoffmann-La Roche

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    L01EX14
  22. enzalutamide

    XTANDI Astellas Pharma Inc

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    L02BB04
  23. epcoritamab-bysp

    EPKINLY

    SUBCUTANEOUS FDA: approved

  24. ephedrine hydrochloride

    REZIPRES

    INTRAVENOUS FDA: approved

Frequently asked questions

How many fda approved drugs are listed?

2,719 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.